Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord.

PubWeight™: 1.98‹?› | Rank: Top 2%

🔗 View Article (PMID 12151546)

Published in J Neurosci on August 01, 2002

Authors

Toshihiro Takami1, Martin Oudega, Margaret L Bates, Patrick M Wood, Naomi Kleitman, Mary Bartlett Bunge

Author Affiliations

1: The Chambers Family Laboratory of Electron Microscopy, The Miami Project to Cure Paralysis, University of Miami School of Medicine, Miami, Florida 33136, USA.

Articles citing this

A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma (2010) 1.95

Stem cell-based therapies for spinal cord injury. J Spinal Cord Med (2009) 1.77

Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells (2010) 1.63

Novel combination strategies to repair the injured mammalian spinal cord. J Spinal Cord Med (2008) 1.38

Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol (2008) 1.36

GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia (2009) 1.26

Cellular transplantation strategies for spinal cord injury and translational neurobiology. NeuroRx (2004) 1.23

Basic advances and new avenues in therapy of spinal cord injury. Annu Rev Med (2004) 1.22

Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng Part A (2009) 1.21

Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol (2007) 1.13

Histological and functional benefit following transplantation of motor neuron progenitors to the injured rat spinal cord. PLoS One (2010) 1.10

Feasibility of combination allogeneic stem cell therapy for spinal cord injury: a case report. Int Arch Med (2010) 1.09

Identified olfactory ensheathing cells transplanted into the transected dorsal funiculus bridge the lesion and form myelin. J Neurosci (2004) 1.09

Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci (2014) 1.08

Protection of corticospinal tract neurons after dorsal spinal cord transection and engraftment of olfactory ensheathing cells. Glia (2006) 1.07

Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett (2009) 1.03

Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics (2011) 1.01

Transplantation-mediated strategies to promote axonal regeneration following spinal cord injury. Respir Physiol Neurobiol (2009) 1.00

Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Dev Neurobiol (2010) 0.99

Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev (2007) 0.99

Derivation and characterization of monkey embryonic stem cells. Reprod Biol Endocrinol (2004) 0.99

Extensive cell migration, axon regeneration, and improved function with polysialic acid-modified Schwann cells after spinal cord injury. Glia (2012) 0.98

Molecular reconstruction of nodes of Ranvier after remyelination by transplanted olfactory ensheathing cells in the demyelinated spinal cord. J Neurosci (2006) 0.98

Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord. Acta Biomater (2009) 0.97

The therapeutic profile of rolipram, PDE target and mechanism of action as a neuroprotectant following spinal cord injury. PLoS One (2012) 0.97

Functional recovery in rats with chronic spinal cord injuries after exposure to an enriched environment. J Spinal Cord Med (2007) 0.96

Development of a universal measure of quadrupedal forelimb-hindlimb coordination using digital motion capture and computerised analysis. BMC Neurosci (2007) 0.94

Comparison of polymer scaffolds in rat spinal cord: a step toward quantitative assessment of combinatorial approaches to spinal cord repair. Biomaterials (2011) 0.93

Axon regeneration through scaffold into distal spinal cord after transection. J Neurotrauma (2009) 0.93

Ectopic expression of polysialylated neural cell adhesion molecule in adult macaque Schwann cells promotes their migration and remyelination potential in the central nervous system. Brain (2009) 0.92

Remyelination of spinal cord axons by olfactory ensheathing cells and Schwann cells derived from a transgenic rat expressing alkaline phosphatase marker gene. Neuron Glia Biol (2004) 0.92

Myelination and nodal formation of regenerated peripheral nerve fibers following transplantation of acutely prepared olfactory ensheathing cells. Brain Res (2006) 0.90

Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation. Exp Neurol (2012) 0.90

Tuba1a gene expression is regulated by KLF6/7 and is necessary for CNS development and regeneration in zebrafish. Mol Cell Neurosci (2010) 0.89

Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng Part A (2011) 0.89

Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury. Neurosci Lett (2009) 0.89

Combination therapies in the CNS: engineering the environment. Neurosci Lett (2012) 0.88

A retinoic acid receptor beta agonist (CD2019) overcomes inhibition of axonal outgrowth via phosphoinositide 3-kinase signalling in the injured adult spinal cord. Neurobiol Dis (2009) 0.88

LacZ-expressing olfactory ensheathing cells do not associate with myelinated axons after implantation into the compressed spinal cord. Proc Natl Acad Sci U S A (2004) 0.88

Suspension matrices for improved Schwann-cell survival after implantation into the injured rat spinal cord. J Neurotrauma (2010) 0.88

Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion. BMC Neurosci (2013) 0.87

Regenerative medicine for the treatment of spinal cord injury: more than just promises? J Cell Mol Med (2012) 0.87

Remyelination of the injured spinal cord. Prog Brain Res (2007) 0.87

Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells. PLoS One (2013) 0.86

Human umbilical cord mesenchymal stem cell-loaded amniotic membrane for the repair of radial nerve injury. Neural Regen Res (2013) 0.86

Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases. Adv Biomed Res (2012) 0.86

Remyelination of the nonhuman primate spinal cord by transplantation of H-transferase transgenic adult pig olfactory ensheathing cells. FASEB J (2003) 0.85

CNPase expression in olfactory ensheathing cells. J Biomed Biotechnol (2011) 0.84

Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration. Stem Cells Int (2015) 0.84

Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci (2015) 0.83

Dissociated predegenerated peripheral nerve transplants for spinal cord injury repair: a comprehensive assessment of their effects on regeneration and functional recovery compared to Schwann cell transplants. J Neurotrauma (2012) 0.83

Female Rats Demonstrate Improved Locomotor Recovery and Greater Preservation of White and Gray Matter after Traumatic Spinal Cord Injury Compared to Males. J Neurotrauma (2015) 0.83

Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice. Cell Transplant (2010) 0.82

Neural crest and olfactory system: new prospective. Mol Neurobiol (2012) 0.82

Mesenchymal stem cells as an alternative for Schwann cells in rat spinal cord injury. Iran Biomed J (2013) 0.82

Role of endogenous Schwann cells in tissue repair after spinal cord injury. Neural Regen Res (2013) 0.81

A calpain inhibitor enhances the survival of Schwann cells in vitro and after transplantation into the injured spinal cord. J Neurotrauma (2010) 0.81

Schwann-spheres derived from injured peripheral nerves in adult mice--their in vitro characterization and therapeutic potential. PLoS One (2011) 0.81

Prolonged minocycline treatment impairs motor neuronal survival and glial function in organotypic rat spinal cord cultures. PLoS One (2013) 0.81

Strategies for regenerating injured axons after spinal cord injury - insights from brain development. Biologics (2008) 0.80

Partial functional recovery after complete spinal cord transection by combined chondroitinase and clenbuterol treatment. Pflugers Arch (2010) 0.80

The potential for cellular therapy combined with growth factors in spinal cord injury. Stem Cells Int (2012) 0.80

Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries. Neural Regen Res (2012) 0.79

Current and future medical therapeutic strategies for the functional repair of spinal cord injury. World J Orthop (2015) 0.79

Efficacy of Schwann cell transplantation for spinal cord repair is improved with combinatorial strategies. J Physiol (2016) 0.79

Characterizing phospholipase A2-induced spinal cord injury-a comparison with contusive spinal cord injury in adult rats. Transl Stroke Res (2011) 0.78

Long-term survival, axonal growth-promotion, and myelination of Schwann cells grafted into contused spinal cord in adult rats. Exp Neurol (2014) 0.78

Does being female provide a neuroprotective advantage following spinal cord injury? Neural Regen Res (2015) 0.78

Treadmill exercise facilitates recovery of locomotor function through axonal regeneration following spinal cord injury in rats. J Exerc Rehabil (2016) 0.78

Changes in CLIP3 expression after sciatic nerve injury in adult rats. J Mol Histol (2012) 0.77

Cellular and paracellular transplants for spinal cord injury: a review of the literature. Childs Nerv Syst (2010) 0.77

Neural precursor cell transplantation enhances functional recovery and reduces astrogliosis in bilateral compressive/contusive cervical spinal cord injury. Stem Cells Transl Med (2014) 0.77

iPS cell transplantation for traumatic spinal cord injury. Curr Stem Cell Res Ther (2016) 0.76

Rapid assessment of internodal myelin integrity in central nervous system tissue. J Neurosci Res (2010) 0.76

Phase 1 Trial of Autologous Bone Marrow Stem Cell Transplantation in Patients with Spinal Cord Injury. Stem Cells Int (2016) 0.76

Acute Putrescine Supplementation with Schwann Cell Implantation Improves Sensory and Serotonergic Axon Growth and Functional Recovery in Spinal Cord Injured Rats. Neural Plast (2015) 0.76

Does the preclinical evidence for functional remyelination following myelinating cell engraftment into the injured spinal cord support progression to clinical trials? Exp Neurol (2016) 0.76

Cellular therapies for treating pain associated with spinal cord injury. J Transl Med (2012) 0.76

Multichannel polymer scaffold seeded with activated Schwann cells and bone mesenchymal stem cells improves axonal regeneration and functional recovery after rat spinal cord injury. Acta Pharmacol Sin (2017) 0.75

Human olfactory mesenchymal stromal cell transplants promote remyelination and earlier improvement in gait co-ordination after spinal cord injury. Glia (2017) 0.75

Superparamagnetic Iron Oxide Nanoparticle-Mediated Forces Enhance the Migration of Schwann Cells Across the Astrocyte-Schwann Cell Boundary In vitro. Front Cell Neurosci (2017) 0.75

Optogenetics applications for treating spinal cord injury. Asian Spine J (2015) 0.75

Cell transplantation therapy for spinal cord injury. Nat Neurosci (2017) 0.75

Olfactory ensheathing cell transplantation for spinal cord injury: An 18-year bibliometric analysis based on the Web of Science. Neural Regen Res (2013) 0.75

The Glia Response after Peripheral Nerve Injury: A Comparison between Schwann Cells and Olfactory Ensheathing Cells and Their Uses for Neural Regenerative Therapies. Int J Mol Sci (2017) 0.75

Biphasic bisperoxovanadium administration and Schwann cell transplantation for repair after cervical contusive spinal cord injury. Exp Neurol (2014) 0.75

Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity. Sci Rep (2016) 0.75

Effects of microtubule-associated protein tau expression on neural stem cell migration after spinal cord injury. Neural Regen Res (2016) 0.75

The Utility of 3D Ultramicroscopy for Evaluating Cellular Therapies After Spinal Cord Injury. Top Spinal Cord Inj Rehabil (2012) 0.75

Transplantation of neural stem cells, Schwann cells and olfactory ensheathing cells for spinal cord injury : A Web of Science-based literature analysis. Neural Regen Res (2012) 0.75

Articles by these authors

cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med (2004) 3.65

Replication and reproducibility in spinal cord injury research. Exp Neurol (2011) 2.31

Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med (2007) 2.29

Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma (2006) 1.88

Chronically CNS-injured adult sensory neurons gain regenerative competence upon a lesion of their peripheral axon. Curr Biol (2009) 1.79

Stem cell-based therapies for spinal cord injury. J Spinal Cord Med (2009) 1.77

Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci (2005) 1.75

Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia (2007) 1.60

Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol (2005) 1.41

Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury. Exp Neurol (2010) 1.40

Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications. J Neural Eng (2008) 1.40

New functional electrical stimulation approaches to standing and walking. J Neural Eng (2007) 1.33

Freeze-dried poly(D,L-lactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials (2004) 1.29

N-cadherin mediates axon-aligned process growth and cell-cell interaction in rat Schwann cells. J Neurosci (2002) 1.28

GDNF-enhanced axonal regeneration and myelination following spinal cord injury is mediated by primary effects on neurons. Glia (2009) 1.26

Robust CNS regeneration after complete spinal cord transection using aligned poly-L-lactic acid microfibers. Biomaterials (2011) 1.23

New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol (2002) 1.21

Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? J Neurotrauma (2004) 1.21

Labeled Schwann cell transplantation: cell loss, host Schwann cell replacement, and strategies to enhance survival. Glia (2006) 1.17

Schwann cell dedifferentiation is independent of mitogenic signaling and uncoupled to proliferation: role of cAMP and JNK in the maintenance of the differentiated state. J Biol Chem (2010) 1.15

Cyclic AMP synergistically enhances neuregulin-dependent ERK and Akt activation and cell cycle progression in Schwann cells. Glia (2006) 1.14

Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation. J Biol Chem (2008) 1.13

Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol (2007) 1.13

A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury. J Neurotrauma (2010) 1.13

Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem (2009) 1.13

Neurotrophic factors improve motoneuron survival and function of muscle reinnervated by embryonic neurons. J Neuropathol Exp Neurol (2009) 1.11

Delayed transplantation of olfactory ensheathing glia promotes sparing/regeneration of supraspinal axons in the contused adult rat spinal cord. J Neurotrauma (2003) 1.11

Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci (2014) 1.08

Role of N-cadherin in Schwann cell precursors of growing nerves. Glia (2006) 1.08

A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model. Brain Res (2008) 1.08

The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces. Mol Cell Neurosci (2005) 1.08

Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant (2006) 1.08

Using the Spinal Cord Injury Common Data Elements. Top Spinal Cord Inj Rehabil (2012) 1.08

Lentiviral vector-mediated transduction of neural progenitor cells before implantation into injured spinal cord and brain to detect their migration, deliver neurotrophic factors and repair tissue. Restor Neurol Neurosci (2005) 1.06

Poly (D,L-lactic acid) macroporous guidance scaffolds seeded with Schwann cells genetically modified to secrete a bi-functional neurotrophin implanted in the completely transected adult rat thoracic spinal cord. Biomaterials (2005) 1.04

Purified adult ensheathing glia fail to myelinate axons under culture conditions that enable Schwann cells to form myelin. J Neurosci (2002) 1.04

Combinatorial strategies with Schwann cell transplantation to improve repair of the injured spinal cord. Neurosci Lett (2009) 1.03

Sialidase enhances recovery from spinal cord contusion injury. Proc Natl Acad Sci U S A (2010) 1.02

Deoxyribozyme-mediated knockdown of xylosyltransferase-1 mRNA promotes axon growth in the adult rat spinal cord. Brain (2008) 1.02

Endothelial cell loss is not a major cause of neuronal and glial cell death following contusion injury of the spinal cord. Exp Neurol (2006) 1.00

Methylprednisolone and interleukin-10 reduce gray matter damage in the contused Fischer rat thoracic spinal cord but do not improve functional outcome. J Neurotrauma (2002) 0.99

GABAA receptor subunit mRNA expression in cultured embryonic and adult human dorsal root ganglion neurons. Brain Res Dev Brain Res (2004) 0.98

Non-antagonistic relationship between mitogenic factors and cAMP in adult Schwann cell re-differentiation. Glia (2009) 0.98

Schwann cell transplantation: a repair strategy for spinal cord injury? Prog Brain Res (2012) 0.96

FA2H is responsible for the formation of 2-hydroxy galactolipids in peripheral nervous system myelin. J Lipid Res (2007) 0.96

Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord. Eur J Neurosci (2007) 0.95

Basic fibroblast growth factor promotes neuronal survival but not behavioral recovery in the transected and Schwann cell implanted rat thoracic spinal cord. J Neurotrauma (2004) 0.95

Inhibition of N-cadherin and beta-catenin function reduces axon-induced Schwann cell proliferation. J Neurosci Res (2008) 0.95

Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough? Exp Neurol (2013) 0.94

Muscle injection of AAV-NT3 promotes anatomical reorganization of CST axons and improves behavioral outcome following SCI. J Neurotrauma (2009) 0.94

Neurotrophins reduce degeneration of injured ascending sensory and corticospinal motor axons in adult rat spinal cord. Exp Neurol (2002) 0.94

The actin-severing protein cofilin is downstream of neuregulin signaling and is essential for Schwann cell myelination. J Neurosci (2012) 0.93

Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate- and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells. Exp Eye Res (2009) 0.93

Invariant mantling of growth cones by Schwann cell precursors characterize growing peripheral nerve fronts. Glia (2006) 0.92

Bone marrow stromal cell-mediated tissue sparing enhances functional repair after spinal cord contusion in adult rats. Cell Transplant (2012) 0.91

A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury. Exp Neurol (2008) 0.91

Skin incision induces expression of axonal regeneration-related genes in adult rat spinal sensory neurons. J Pain (2010) 0.89

Schwann-cell injection of cold-preserved nerve allografts. Microsurgery (2005) 0.89

Nuclear factor-κB activation in Schwann cells regulates regeneration and remyelination. Glia (2012) 0.89

Outcome Measures for Acute/Subacute Cervical Sensorimotor Complete (AIS-A) Spinal Cord Injury During a Phase 2 Clinical Trial. Top Spinal Cord Inj Rehabil (2012) 0.89

Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus. Rev Neurosci (2015) 0.88

Improved immunocytochemical identification of neural, endothelial, and inflammatory cell types in paraffin-embedded injured adult rat spinal cord. J Neurosci Methods (2004) 0.88

Ligand binding and membrane insertion compete with oligomerization of the BclXL apoptotic repressor. J Mol Biol (2011) 0.88

Bone marrow stromal cells elicit tissue sparing after acute but not delayed transplantation into the contused adult rat thoracic spinal cord. J Neurotrauma (2009) 0.88

Direct gene therapy for repair of the spinal cord. J Neurotrauma (2006) 0.87

Restoring function after spinal cord injury: promoting spontaneous regeneration with stem cells and activity-based therapies. Neurosurg Clin N Am (2007) 0.87

Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA. Glia (2005) 0.87

Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages. Eur J Neurosci (2004) 0.86

BMP signaling initiates a neural crest differentiation program in embryonic rat CNS stem cells. Exp Neurol (2004) 0.86

Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia. Biomaterials (2012) 0.85

Permissive Schwann cell graft/spinal cord interfaces for axon regeneration. Cell Transplant (2013) 0.85

From animal models to humans: strategies for promoting CNS axon regeneration and recovery of limb function after spinal cord injury. J Neurol Phys Ther (2005) 0.85

Sialidase, chondroitinase ABC, and combination therapy after spinal cord contusion injury. J Neurotrauma (2013) 0.84

Combining neurotrophin-transduced schwann cells and rolipram to promote functional recovery from subacute spinal cord injury. Cell Transplant (2012) 0.84

Positron emission tomography for serial imaging of the contused adult rat spinal cord. Mol Imaging (2010) 0.83

Motoneuron replacement for reinnervation of skeletal muscle in adult rats. J Neuropathol Exp Neurol (2012) 0.83